rxstat › Shortages › Oseltamivir
Oseltamivir shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Oseltamivir products are in shortage in Canada (1 of 6 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
In shortage since
Dec 31, 2025
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageNAT-OSELTAMIVIR
6MG · POWDER FOR SUSPENSION · NATCO PHARMA (CANADA) INC
DIN 02499894 · since Dec 31, 2025, no end estimate · Demand increase for the drug.
ResolvedJAMP OSELTAMIVIR
75MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02497425 · ended Apr 30, 2026 · Demand increase for the drug.
ResolvedTAMIFLU
6MG · POWDER FOR SUSPENSION · HOFFMANN-LA ROCHE LIMITED
DIN 02381842 · ended Mar 3, 2026 · Demand increase for the drug.
ResolvedTAMIFLU
75MG · CAPSULE · HOFFMANN-LA ROCHE LIMITED
DIN 02241472 · ended Feb 22, 2026 · Demand increase for the drug.
ResolvedJAMP OSELTAMIVIR
30MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02497409 · ended Feb 11, 2026 · Disruption of the manufacture of the drug.
ResolvedMINT-OSELTAMIVIR
75MG · CAPSULE · MINT PHARMACEUTICALS INC
DIN 02497476 · ended Oct 18, 2023 · Disruption of the manufacture of the drug.
ResolvedJAMP OSELTAMIVIR
75MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02497425 · ended Sep 19, 2023 · Other (Please describe in comments)
ResolvedJAMP OSELTAMIVIR
75MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02497425 · ended Feb 1, 2023 · Demand increase for the drug.
ResolvedTAMIFLU
75MG · CAPSULE · HOFFMANN-LA ROCHE LIMITED
DIN 02241472 · ended Dec 14, 2022 · Demand increase for the drug.
ResolvedTAMIFLU
6MG · POWDER FOR SUSPENSION · HOFFMANN-LA ROCHE LIMITED
DIN 02381842 · ended Dec 9, 2022 · Demand increase for the drug.
ResolvedJAMP OSELTAMIVIR
75MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02497425 · ended Jul 19, 2022 · Disruption of the manufacture of the drug.
ResolvedTAMIFLU
6MG · POWDER FOR SUSPENSION · HOFFMANN-LA ROCHE LIMITED
DIN 02381842 · ended Apr 20, 2020 · Demand increase for the drug.
Showing 12 of 13 reports. All reports are on file with Health Canada.
What's happening
Oseltamivir is currently affected by an active shortage report filed with Health Canada by NATCO PHARMA (CANADA) INC.
The reported cause is: demand increase for the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Oseltamivir is classified under “DIRECT ACTING ANTIVIRALS” (ATC J05AH).
Recent changes
Common questions
When will Oseltamivir be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Oseltamivir in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.